<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">surgonco</journal-id><journal-title-group><journal-title xml:lang="ru">Креативная хирургия и онкология</journal-title><trans-title-group xml:lang="en"><trans-title>Creative surgery and oncology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2076-3093</issn><issn pub-type="epub">2307-0501</issn><publisher><publisher-name>Башкирский государственный медицинский университет</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24060/2076-3093-2017-7-2-54-61</article-id><article-id custom-type="elpub" pub-id-type="custom">surgonco-231</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW</subject></subj-group></article-categories><title-group><article-title>СВОБОДНОРАДИКАЛЬНОЕ ОКИСЛЕНИЕ И КАНЦЕРОГЕНЕЗ: ДИСКУССИОННЫЕ ВОПРОСЫ</article-title><trans-title-group xml:lang="en"><trans-title>FREE RADICAL OXIDATION AND CARCINOGENESIS: DEBATABLE ISSUES</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2125-4897</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Павлов</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Pavlov</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0371-0385</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рахматуллина</surname><given-names>И. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Rakhmatullina</surname><given-names>I. R.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9471-6952</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фархутдинов</surname><given-names>Р. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Farkhutdinov</surname><given-names>R. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Фархутдинов Рафагат Равильевич – доктор медицинских наук, профессор, ведущий научный сотрудник Центральной научной исследовательской лаборатории </p><p>450008, Россия, Башкортостан, Уфа, ул. Ленина, д.3</p></bio><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2620-9796</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пушкарев</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Pushkarev</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"/><bio xml:lang="en"/><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4374-2923</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Данилко</surname><given-names>К. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Danilko</surname><given-names>K. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Данилко Ксения Владимировна – кандидат биологических наук, руководитель лаборатории клеточных культур, старший научный сотрудник Центральной научно-исследовательской лаборатории </p><p>450008, Россия, Башкортостан, Уфа, ул. Ленина, д.3</p></bio><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3351-7669</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Галимова</surname><given-names>Э. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Galimova</surname><given-names>E. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Галимова Эльмира Фанисовна – доктор медицинских наук, ведущий научный сотрудник Центральной научно-исследовательской лаборатории </p><p>450008, Россия, Башкортостан, Уфа, ул. Ленина, д.3</p></bio><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5839-9793</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Баймурзина</surname><given-names>Ю. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Baimurzina</surname><given-names>Ju. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Баймурзина Юлия Львовна – кандидат биологических наук, научный сотрудник Центральной научно-исследовательской лаборатории </p><p>450008, Россия, Башкортостан, Уфа, ул. Ленина, д.3</p></bio><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0669-6144</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петрова</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Petrova</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Петрова Ирина Владимировна – младший научный сотрудник Центральной научно-исследовательской лаборатории </p><p>450008, Россия, Башкортостан, Уфа, ул. Ленина, д.3</p></bio><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8010-3338</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мочалов</surname><given-names>К. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Mochalov</surname><given-names>K. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мочалов Константин Сергеевич – кандидат биологических наук, заведующий Центральной научно-исследовательской лабораторией </p><p>450008, Россия, Башкортостан, Уфа, ул. Ленина, д.3</p></bio><bio xml:lang="en"/><email xlink:type="simple">cnil@bashgmu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Башкирский государственный медицинский университет» Министерства здравоохранения Российской Федерации,</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Bashkir State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Государственное бюджетное учреждение здравоохранения «Республиканский клинический онкологический диспансер»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Republican Clinical Oncology Dispensary</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>08</day><month>07</month><year>2017</year></pub-date><volume>7</volume><issue>2</issue><fpage>54</fpage><lpage>61</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Павлов В.Н., Рахматуллина И.Р., Фархутдинов Р.Р., Пушкарев В.А., Данилко К.В., Галимова Э.Ф., Баймурзина Ю.Л., Петрова И.В., Мочалов К.С., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Павлов В.Н., Рахматуллина И.Р., Фархутдинов Р.Р., Пушкарев В.А., Данилко К.В., Галимова Э.Ф., Баймурзина Ю.Л., Петрова И.В., Мочалов К.С.</copyright-holder><copyright-holder xml:lang="en">Pavlov V.N., Rakhmatullina I.R., Farkhutdinov R.R., Pushkarev V.A., Danilko K.V., Galimova E.F., Baimurzina J.L., Petrova I.V., Mochalov K.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.surgonco.ru/jour/article/view/231">https://www.surgonco.ru/jour/article/view/231</self-uri><abstract><p>Свободные радикалы заняли прочное место среди принципов, объясняющих возникновения и развития опухолей. До сих пор нет однозначных представлений о роли этих чрезвычайно активных агентов в канцерогенезе. Экспериментальные результаты носят противоречивый, зачастую противоположный характер. Область исследования значения активности антиоксидантных систем по полученным результатам является не менее спорной. В связи с этим, актуальной проблемой является необходимость назначения антиоксидантов при онкологии. Противоопухолевые эффекты антиоксидантов ставятся под сомнение во многих работах, что выдвигает на передний план целесообразность и адекватность их назначения. Неоднозначная роль свободных радикалов в канцерогенезе обусловливает разработку терапевтических стратегий, основанных на точной модуляции окислительных процессов. </p></abstract><trans-abstract xml:lang="en"><p>Free radicals have taken a firm place among the explanatory principles of the onset and development of tumors. Unambiguous ideas about the role of these highly active agents in carcinogenesis have not yet been obtained. The experimental results are contradictory, often the opposite. The field of study of the value of the activity of antioxidant systems based on the results obtained is no less controversial. In this regard, the urgent problem is the need to prescribe antioxidants in oncology. Antitumor effects of antioxidants are being questioned in many works, which brings to the forefront the appropriateness and adequacy of their appointment. The ambiguous role of free radicals in carcinogenesis determines the development of therapeutic strategies based on the precise modulation of oxidative processes.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>свободные радикалы</kwd><kwd>опухоли</kwd><kwd>рак</kwd><kwd>противоопухолевые препараты</kwd><kwd>антиоксиданты</kwd></kwd-group><kwd-group xml:lang="en"><kwd>free radicals</kwd><kwd>tumors</kwd><kwd>cancer</kwd><kwd>anti-cancer drugs</kwd><kwd>antioxidants</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Шапошников АВ, Рядинская ЛА. Канцерогенез и оксидативный стресс. Кубанский научный медицинский вестник. 2010;(3-4):211-215. [Shaposhnikov AV, Rjadinskaja LA. Cancerogenesis and oxidative stress. Kuban Scientific Medical Bulletin. 2010;(3-4):211-15 (in Russ.)].</mixed-citation><mixed-citation xml:lang="en">Шапошников АВ, Рядинская ЛА. Канцерогенез и оксидативный стресс. Кубанский научный медицинский вестник. 2010;(3-4):211-215. [Shaposhnikov AV, Rjadinskaja LA. Cancerogenesis and oxidative stress. Kuban Scientific Medical Bulletin. 2010;(3-4):211-15 (in Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Schumacker PT. Reactive oxygen species in cancer: a dance with the devil. Cancer Cell. 2015; 27(2):156-7. DOI: 10.1016/j.ccell.2015.01.007.</mixed-citation><mixed-citation xml:lang="en">Schumacker PT. Reactive oxygen species in cancer: a dance with the devil. Cancer Cell. 2015; 27(2):156-7. DOI: 10.1016/j.ccell.2015.01.007.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Martinez-Outschoorn UE, Balliet RM, Rivadeneira DB, Chiavarina B, Pavlides S, Wang C, et al. Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: a new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell Cycle. 2010;9(16):3256-76. DOI: 10.4161/cc.9.16.12553.</mixed-citation><mixed-citation xml:lang="en">Martinez-Outschoorn UE, Balliet RM, Rivadeneira DB, Chiavarina B, Pavlides S, Wang C, et al. Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: a new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell Cycle. 2010;9(16):3256-76. DOI: 10.4161/cc.9.16.12553.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Shrihari TG. Dual role of inflammatory mediators in cancer. Ecancermedicalscience. 2017;11:721. DOI: 10.3332/ecancer.2017.721.</mixed-citation><mixed-citation xml:lang="en">Shrihari TG. Dual role of inflammatory mediators in cancer. Ecancermedicalscience. 2017;11:721. DOI: 10.3332/ecancer.2017.721.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Katakwar P, Metgud R, Naik S, Mittal R. Oxidative stress marker in oral cancer: a review. J Cancer Res Ther. 2016;12(2):438-46. DOI:10.4103/09731482.151935.</mixed-citation><mixed-citation xml:lang="en">Katakwar P, Metgud R, Naik S, Mittal R. Oxidative stress marker in oral cancer: a review. J Cancer Res Ther. 2016;12(2):438-46. DOI:10.4103/09731482.151935.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Martinez-Useros J, Li W, Cabeza-Morales M, Garcia-Foncillas J. Oxidative stress: a new target for pancreatic cancer prognosis and treatment. J Clin Med. 2017;6(3):29. DOI:10.3390/jcm6030029.</mixed-citation><mixed-citation xml:lang="en">Martinez-Useros J, Li W, Cabeza-Morales M, Garcia-Foncillas J. Oxidative stress: a new target for pancreatic cancer prognosis and treatment. J Clin Med. 2017;6(3):29. DOI:10.3390/jcm6030029.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Juhasz A, Markel S, Gaur S, Liu H, Lu J, Jiang G, et al. NADPH oxidase 1 supports proliferation of colon cancer cells by modulating reactive oxygen species-dependent signal transduction. J Biol Chem. 2017;292(19): 7866-87. DOI: 10.1074/jbc.M116.768283.</mixed-citation><mixed-citation xml:lang="en">Juhasz A, Markel S, Gaur S, Liu H, Lu J, Jiang G, et al. NADPH oxidase 1 supports proliferation of colon cancer cells by modulating reactive oxygen species-dependent signal transduction. J Biol Chem. 2017;292(19): 7866-87. DOI: 10.1074/jbc.M116.768283.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Saed GM, Diamond MP, Fletcher NM. Updates of the role of oxidative stress in the pathogenesis of ovarian cancer. Gynecol Oncol. 2017 Feb 23. Epub ahead of print. DOI: 10.1016/j.ygyno.2017.02.033.</mixed-citation><mixed-citation xml:lang="en">Saed GM, Diamond MP, Fletcher NM. Updates of the role of oxidative stress in the pathogenesis of ovarian cancer. Gynecol Oncol. 2017 Feb 23. Epub ahead of print. DOI: 10.1016/j.ygyno.2017.02.033.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Valavanidis A, Vlachogianni T, Fiotakis K, Loridas S. Pulmonary oxidative stress, inflammation and cancer: respirable particulate matter, fibrous dusts and ozone as major causes of lung carcinogenesis through reactive oxygen species mechanisms. Int J Environ Res Publ. Health. 2013;10(9):3886-907. DOI:10.3390/ijerph10093886.</mixed-citation><mixed-citation xml:lang="en">Valavanidis A, Vlachogianni T, Fiotakis K, Loridas S. Pulmonary oxidative stress, inflammation and cancer: respirable particulate matter, fibrous dusts and ozone as major causes of lung carcinogenesis through reactive oxygen species mechanisms. Int J Environ Res Publ. Health. 2013;10(9):3886-907. DOI:10.3390/ijerph10093886.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Looi ML, Mohd Dali AZ, Md Ali SA, Wan Ngah WZ, Mohd Yusof YA. Oxidative damage and antioxidant status in patients with cervical intraepithelial neoplasia and carcinoma of the cervix. Eur J Cancer Prev. 2008;17(6):555-60. DOI: 10.1097/CEJ.0b013e328305a10b.</mixed-citation><mixed-citation xml:lang="en">Looi ML, Mohd Dali AZ, Md Ali SA, Wan Ngah WZ, Mohd Yusof YA. Oxidative damage and antioxidant status in patients with cervical intraepithelial neoplasia and carcinoma of the cervix. Eur J Cancer Prev. 2008;17(6):555-60. DOI: 10.1097/CEJ.0b013e328305a10b.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Marinescu S, Anghel R, Gruia MI, Beuran M. Involvement of reactive oxygen species in the mechanisms associated with cervical cancer specific treatment. Chirurgia (Bucur). 2014;109(6):806-11. PMID: 25560505.</mixed-citation><mixed-citation xml:lang="en">Marinescu S, Anghel R, Gruia MI, Beuran M. Involvement of reactive oxygen species in the mechanisms associated with cervical cancer specific treatment. Chirurgia (Bucur). 2014;109(6):806-11. PMID: 25560505.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Емельянов МО, Ким ЮА, Корыстова АФ, Кублик ЛН, Шапошникова ВВ, Корыстов ЮН. Быстрое подавление множественной лекарственной устойчивости лейкозных клеток окислительным стрессом. Биологические мембраны: Журнал мембранной и клеточной биологии. 2010;27(3):244251. [EmelYanov MO, Korystova AF, Kublik LN, Shaposhnikova VV, Korystov YuN, Kim YuA. Rapid suppression of multidrug resistance of leukemic cells by oxidative stress. Biochemistry (Moscow) Supplement. Series A: Membrane and Cell Biology. 2010;4(2):212219]. DOI: 10.1134/S1990747810020133.</mixed-citation><mixed-citation xml:lang="en">Емельянов МО, Ким ЮА, Корыстова АФ, Кублик ЛН, Шапошникова ВВ, Корыстов ЮН. Быстрое подавление множественной лекарственной устойчивости лейкозных клеток окислительным стрессом. Биологические мембраны: Журнал мембранной и клеточной биологии. 2010;27(3):244251. [EmelYanov MO, Korystova AF, Kublik LN, Shaposhnikova VV, Korystov YuN, Kim YuA. Rapid suppression of multidrug resistance of leukemic cells by oxidative stress. Biochemistry (Moscow) Supplement. Series A: Membrane and Cell Biology. 2010;4(2):212219]. DOI: 10.1134/S1990747810020133.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Рязанцева НВ, Степовая ЕА, Коновалова ЕВ, Носарева ОЛ, Наумова АИ, Орлов ДС, и др. Моделирование окислительного стресса в лимфоцитах крови in vitro для изучения апоптоза опухолевых клеток линии JURKAT. Казанский медицинский журнал. 2013;94(5):736-740. [Ryazantseva NV, Stepovaya EA, Konovalova EV, Nosareva OL, Naumova AI, Orlov DS, et al. Oxidative stress modeling in the blood lymphocytes in vitro to examine the jurkat line tumor cells apoptosis. Kazan Medical Journal. 2013;94(5):736-740 (in Russ.)].</mixed-citation><mixed-citation xml:lang="en">Рязанцева НВ, Степовая ЕА, Коновалова ЕВ, Носарева ОЛ, Наумова АИ, Орлов ДС, и др. Моделирование окислительного стресса в лимфоцитах крови in vitro для изучения апоптоза опухолевых клеток линии JURKAT. Казанский медицинский журнал. 2013;94(5):736-740. [Ryazantseva NV, Stepovaya EA, Konovalova EV, Nosareva OL, Naumova AI, Orlov DS, et al. Oxidative stress modeling in the blood lymphocytes in vitro to examine the jurkat line tumor cells apoptosis. Kazan Medical Journal. 2013;94(5):736-740 (in Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Шахристова ЕВ, Рязанцева НВ, Степовая ЕА, Носарева ОЛ. Индукция пероксидом водорода окислительного стресса in vitro в эпителиальных клетках молочной железы для изучения апоптоза опухолевых клеток линии MCF-7. Сибирский научный медицинский журнал. 2015;35(2):510. [Shakhristova EV, Ryazantseva NV, Stepovaya EA, Nosareva OL. Induction of oxidative stress by hydrogen peroxide in vitro in breast epithelial cells for studying MCF-7 tumor cell line apoptosis. Siberian Scientific Medical Journal. 2015;35(2):5-10 (in Russ.)].</mixed-citation><mixed-citation xml:lang="en">Шахристова ЕВ, Рязанцева НВ, Степовая ЕА, Носарева ОЛ. Индукция пероксидом водорода окислительного стресса in vitro в эпителиальных клетках молочной железы для изучения апоптоза опухолевых клеток линии MCF-7. Сибирский научный медицинский журнал. 2015;35(2):510. [Shakhristova EV, Ryazantseva NV, Stepovaya EA, Nosareva OL. Induction of oxidative stress by hydrogen peroxide in vitro in breast epithelial cells for studying MCF-7 tumor cell line apoptosis. Siberian Scientific Medical Journal. 2015;35(2):5-10 (in Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Владимиров ЮА, Проскурнина ЕВ. Свободные радикалы и клеточная хемилюминесценция. Успехи биологической химии. 2009;49:341-388.</mixed-citation><mixed-citation xml:lang="en">Владимиров ЮА, Проскурнина ЕВ. Свободные радикалы и клеточная хемилюминесценция. Успехи биологической химии. 2009;49:341-388.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Lyamzaev KG, Pustovidko AV, Simonyan RA, Rokitskaya TI, Domnina LV, Ivanova OYu, et al. Novel mitochondria-targeted antioxidants: plastoquinone conjugated with cationic plant alkaloids berberine and palmatine. Pharm Res. 2011;28(11):2883-2895. DOI: 10.1007/s11095-011-0504-8.</mixed-citation><mixed-citation xml:lang="en">Lyamzaev KG, Pustovidko AV, Simonyan RA, Rokitskaya TI, Domnina LV, Ivanova OYu, et al. Novel mitochondria-targeted antioxidants: plastoquinone conjugated with cationic plant alkaloids berberine and palmatine. Pharm Res. 2011;28(11):2883-2895. DOI: 10.1007/s11095-011-0504-8.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Фархутдинов РР, Галимов ШН, Галимова ЭФ. Свободнорадикальное окисление в норме и патологии. Практикующий врач сегодня. 2010;(2):5461. [Farkhutdinov RR, Galimov ShN, Galimova EF. Free radical oxidation in health and disease. Practitioner Doctor Today. 2010;(2):54-61 (in Russ.)].</mixed-citation><mixed-citation xml:lang="en">Фархутдинов РР, Галимов ШН, Галимова ЭФ. Свободнорадикальное окисление в норме и патологии. Практикующий врач сегодня. 2010;(2):5461. [Farkhutdinov RR, Galimov ShN, Galimova EF. Free radical oxidation in health and disease. Practitioner Doctor Today. 2010;(2):54-61 (in Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Barrera G. Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncol. 2012;2012:21. DOI: 10.5402/2012/137289.</mixed-citation><mixed-citation xml:lang="en">Barrera G. Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncol. 2012;2012:21. DOI: 10.5402/2012/137289.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Bhat AH, Dar KB, Anees S, Zargar MA, Masood A, Sofi MA, et al. Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight. Biomed Pharmacother. 2015;74:101-10. DOI: 10.1016/j.biopha.2015.07.025.</mixed-citation><mixed-citation xml:lang="en">Bhat AH, Dar KB, Anees S, Zargar MA, Masood A, Sofi MA, et al. Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight. Biomed Pharmacother. 2015;74:101-10. DOI: 10.1016/j.biopha.2015.07.025.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Lushchak VI. Free radicals, reactive oxygen species, oxidative stress and its classification. Chem Biol Interact. 2014;224:164-75. DOI: 10.1016/j.cbi.2014.10.016.</mixed-citation><mixed-citation xml:lang="en">Lushchak VI. Free radicals, reactive oxygen species, oxidative stress and its classification. Chem Biol Interact. 2014;224:164-75. DOI: 10.1016/j.cbi.2014.10.016.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Eldridge RC, Flanders WD, Bostick RM, Fedirko V, Gross M, Thyagarajan B, et al. Using multiple biomarkers and determinants to obtain a better measurement of oxidative stress: a latent variable structural equation model approach. Biomarkers. 2017 Mar 29:1-8. Epub ahead of prin. DOI: 10.1080/1354750X.2017.1306752.</mixed-citation><mixed-citation xml:lang="en">Eldridge RC, Flanders WD, Bostick RM, Fedirko V, Gross M, Thyagarajan B, et al. Using multiple biomarkers and determinants to obtain a better measurement of oxidative stress: a latent variable structural equation model approach. Biomarkers. 2017 Mar 29:1-8. Epub ahead of prin. DOI: 10.1080/1354750X.2017.1306752.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Павлов ВН, Галимова ЭФ, Катаев ВА, Фархутдинов РР, Мочалов КС, Баймурзина ЮЛ, и др. Сравнительный анализ антиоксидантных эффектов Коэнзима Q и L-карнитина у мужчин с идиопатической патоспермией. Медицинский вестник Башкортостана. 2013;8(6):161-163. [Pavlov VN, Galimova EF, Kataev VA, Farkhutdinov RR, Mochalov KS, Baimurzina JuL, et al. The comparative analysis of coenzyme Q and L-carnitine antioxidant effects in men with idiopathic pathospermia. Bashkortostan Medical Journal. 2013;8(6):161-163 (in Russ.)].</mixed-citation><mixed-citation xml:lang="en">Павлов ВН, Галимова ЭФ, Катаев ВА, Фархутдинов РР, Мочалов КС, Баймурзина ЮЛ, и др. Сравнительный анализ антиоксидантных эффектов Коэнзима Q и L-карнитина у мужчин с идиопатической патоспермией. Медицинский вестник Башкортостана. 2013;8(6):161-163. [Pavlov VN, Galimova EF, Kataev VA, Farkhutdinov RR, Mochalov KS, Baimurzina JuL, et al. The comparative analysis of coenzyme Q and L-carnitine antioxidant effects in men with idiopathic pathospermia. Bashkortostan Medical Journal. 2013;8(6):161-163 (in Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Павлов ВН, Галимова ЭФ, Мочалов КС, Петрова ИВ, Баймурзина ЮЛ, Зарипова РМ, и др. Оценка влияния L-карнитина на репродуктивную функцию мужчин с идиопатической патоспермией. Медицинский вестник Башкортостана. 2012;7(4):3640. [Pavlov VN, Galimova EF, Mochalov KS, Petrova IV, Baymurzina YuL, Zaripova RM, et al. Estimating l-carnitine influence on reproductive function in men with idiopathic patospermia. Bashkortostan Medical Journal. 2012;7(4):36-40 (in Russ.)].</mixed-citation><mixed-citation xml:lang="en">Павлов ВН, Галимова ЭФ, Мочалов КС, Петрова ИВ, Баймурзина ЮЛ, Зарипова РМ, и др. Оценка влияния L-карнитина на репродуктивную функцию мужчин с идиопатической патоспермией. Медицинский вестник Башкортостана. 2012;7(4):3640. [Pavlov VN, Galimova EF, Mochalov KS, Petrova IV, Baymurzina YuL, Zaripova RM, et al. Estimating l-carnitine influence on reproductive function in men with idiopathic patospermia. Bashkortostan Medical Journal. 2012;7(4):36-40 (in Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Serbanescu GL, Gruia MI, Bara M, Anghel RM. The evaluation of the oxidative stress for patients receiving neoadjuvant chemoradiotherapy for locally advanced rectal cancer. J Med Life. 2017;10(1):99-103. PMID: 28255388.</mixed-citation><mixed-citation xml:lang="en">Serbanescu GL, Gruia MI, Bara M, Anghel RM. The evaluation of the oxidative stress for patients receiving neoadjuvant chemoradiotherapy for locally advanced rectal cancer. J Med Life. 2017;10(1):99-103. PMID: 28255388.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Glasauer A, Chandel NS. Targeting antioxidants for cancer therapy. Biochem Pharmacol. 2014;92(1):90101. DOI: 10.1016/j.bcp.2014.07.017.</mixed-citation><mixed-citation xml:lang="en">Glasauer A, Chandel NS. Targeting antioxidants for cancer therapy. Biochem Pharmacol. 2014;92(1):90101. DOI: 10.1016/j.bcp.2014.07.017.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Кондакова ИВ, Какурина ГВ, Смирнова ЛП, Борунов ЕВ. Регуляция пролиферации и апоптоза опухолевых клеток свободными радикалами. Сибирский онкологический журнал. 2005;(1):58-61. [Kondakova IV, Kakurina GV, Smirnova LP, Borunov EV. Regulation of tumor cell proliferation and apoptosis by free radicals. Siberian Journal of Oncology. 2005;(1):58-61 (in Russ.)].</mixed-citation><mixed-citation xml:lang="en">Кондакова ИВ, Какурина ГВ, Смирнова ЛП, Борунов ЕВ. Регуляция пролиферации и апоптоза опухолевых клеток свободными радикалами. Сибирский онкологический журнал. 2005;(1):58-61. [Kondakova IV, Kakurina GV, Smirnova LP, Borunov EV. Regulation of tumor cell proliferation and apoptosis by free radicals. Siberian Journal of Oncology. 2005;(1):58-61 (in Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Wang J, Yi J. Cancer cell killing via ROS: to increase or decrease, that is the question. Cancer Biol Ther. 2008;7(12):1875-84. PMID: 18981733.</mixed-citation><mixed-citation xml:lang="en">Wang J, Yi J. Cancer cell killing via ROS: to increase or decrease, that is the question. Cancer Biol Ther. 2008;7(12):1875-84. PMID: 18981733.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Prathap Kumar S Mahalingaiah, Kamaleshwar P Singh. Chronic oxidative stress increases growth and tumorigenic potential of MCF-7 breast cancer cells. PLoS One. 2014;9(4):e93799. DOI. 10.1371/journal. pone.0087371.</mixed-citation><mixed-citation xml:lang="en">Prathap Kumar S Mahalingaiah, Kamaleshwar P Singh. Chronic oxidative stress increases growth and tumorigenic potential of MCF-7 breast cancer cells. PLoS One. 2014;9(4):e93799. DOI. 10.1371/journal. pone.0087371.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Kruk J, Aboul-Enein HY. Reactive oxygen and nitrogen species in carcinogenesis: Implications of oxidative stress on the progression and development of several cancer types. Mini Rev Med Chem. 2017 Feb 28. Epub ahead of print. DOI: 10.2174/1389557517666170228115324.</mixed-citation><mixed-citation xml:lang="en">Kruk J, Aboul-Enein HY. Reactive oxygen and nitrogen species in carcinogenesis: Implications of oxidative stress on the progression and development of several cancer types. Mini Rev Med Chem. 2017 Feb 28. Epub ahead of print. DOI: 10.2174/1389557517666170228115324.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Зорькина АВ, Скопин ПИ. Модификация противоопухолевой химиотерапии антиоксидантными препаратами в эксперименте. Cибирский онкологический журнал. 2011;1(43):34-39. [Zorkina AV, Skopin PI. Modification of antitumor therapy with antioxidant drugs in experimental studies. Siberian Journal of Oncology. 2011;1(43):34-39 (in Russ.)].</mixed-citation><mixed-citation xml:lang="en">Зорькина АВ, Скопин ПИ. Модификация противоопухолевой химиотерапии антиоксидантными препаратами в эксперименте. Cибирский онкологический журнал. 2011;1(43):34-39. [Zorkina AV, Skopin PI. Modification of antitumor therapy with antioxidant drugs in experimental studies. Siberian Journal of Oncology. 2011;1(43):34-39 (in Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Лалетин ВС, Колесниченко ЛС. Липоевая кислота как потенциальный прооксидант. Сибирский медицинский журнал (Иркутск). 2010;92(1):7274. [Laletin VS, Kolesnichenko LS. Lipoic acid as a potential prooxidant. Siberian Medical Journal (Irkutsk). 2010;92(1):72-74 (in Russ.)].</mixed-citation><mixed-citation xml:lang="en">Лалетин ВС, Колесниченко ЛС. Липоевая кислота как потенциальный прооксидант. Сибирский медицинский журнал (Иркутск). 2010;92(1):7274. [Laletin VS, Kolesnichenko LS. Lipoic acid as a potential prooxidant. Siberian Medical Journal (Irkutsk). 2010;92(1):72-74 (in Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Микуляк НИ, Миннигалеева СД, Магдеев РР, Кинзирский АС, Микуляк АИ, Соломанина ОО. Оценка влияния карубицина при раздельном и сочетанном применении с пробуколом, мексидолом, -токоферолом на рост первичного опухолевого узла и метастазирование карциномы легких Льюис. Фундаментальные исследования. 2014;7-4:753758. [Mikuleak NI, Minnigaleeva SD, Magdeyev RR, Kinzirsky AS, Mikulyak AL, Solomanina OO. Valuation of the impact of separate and combined use of carubicinum with probucol, mexidol and -tocopherol on the growth of primary tumor and metastasis of lewis lung carcinoma. Fundamental Research. 2014;74:753-758 (in Russ.)].</mixed-citation><mixed-citation xml:lang="en">Микуляк НИ, Миннигалеева СД, Магдеев РР, Кинзирский АС, Микуляк АИ, Соломанина ОО. Оценка влияния карубицина при раздельном и сочетанном применении с пробуколом, мексидолом, -токоферолом на рост первичного опухолевого узла и метастазирование карциномы легких Льюис. Фундаментальные исследования. 2014;7-4:753758. [Mikuleak NI, Minnigaleeva SD, Magdeyev RR, Kinzirsky AS, Mikulyak AL, Solomanina OO. Valuation of the impact of separate and combined use of carubicinum with probucol, mexidol and -tocopherol on the growth of primary tumor and metastasis of lewis lung carcinoma. Fundamental Research. 2014;74:753-758 (in Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Потапова АА, Доркина ЕГ, Сергеева ЕО, Саджая ЛА. Влияние сухого экстракта из корней Шлемника Байкальского (scutellaria baicalensis georgi) на развитие окислительного стресса, вызванного циклофосфаном. Современные проблемы науки и образования. 2013;6:667. [Potapova AA, Dorkina EG, Sergeeva EO, Sadzhaya LA. Effects of dry root extract scutellaria baicalensis georgi on development oxidative stress induced by cyclophosphamide. Modern Problems of Science and Education. 2013;6:667 (in Russ.)].</mixed-citation><mixed-citation xml:lang="en">Потапова АА, Доркина ЕГ, Сергеева ЕО, Саджая ЛА. Влияние сухого экстракта из корней Шлемника Байкальского (scutellaria baicalensis georgi) на развитие окислительного стресса, вызванного циклофосфаном. Современные проблемы науки и образования. 2013;6:667. [Potapova AA, Dorkina EG, Sergeeva EO, Sadzhaya LA. Effects of dry root extract scutellaria baicalensis georgi on development oxidative stress induced by cyclophosphamide. Modern Problems of Science and Education. 2013;6:667 (in Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Скопин ПИ, Скопина ЮА, Евстифеев СВ, Сухова ЛА, Кулаев МТ, Куслина АВ. Антиоксиданты на основе 3-оксипиридинов повышают эффективность противоопухолевых препаратов. Современные проблемы науки и образования. 2016;2:75. [Skopin PI, Skopina YuA, Evstifeev SV, Sukhova LA, Kulaev MT, Kuslina AV. 3-hydroxypyridine based antioxidants increase efficiency of anticancer drugs. Modern Problems of Science and Education. 2016;2:75 (in Russ.)].</mixed-citation><mixed-citation xml:lang="en">Скопин ПИ, Скопина ЮА, Евстифеев СВ, Сухова ЛА, Кулаев МТ, Куслина АВ. Антиоксиданты на основе 3-оксипиридинов повышают эффективность противоопухолевых препаратов. Современные проблемы науки и образования. 2016;2:75. [Skopin PI, Skopina YuA, Evstifeev SV, Sukhova LA, Kulaev MT, Kuslina AV. 3-hydroxypyridine based antioxidants increase efficiency of anticancer drugs. Modern Problems of Science and Education. 2016;2:75 (in Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Tekiner-Gulbas B, Westwell AD, Suzen S. Oxidative stress in carcinogenesis: new synthetic compounds with dual effects upon free radicals and cancer. Curr Med Chem. 2013;20(36):4451-9. PMID: 23834180.</mixed-citation><mixed-citation xml:lang="en">Tekiner-Gulbas B, Westwell AD, Suzen S. Oxidative stress in carcinogenesis: new synthetic compounds with dual effects upon free radicals and cancer. Curr Med Chem. 2013;20(36):4451-9. PMID: 23834180.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C. Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials. Int J Cancer. 2008;123(6):1227-39. DOI: 10.1002/ijc.23754.</mixed-citation><mixed-citation xml:lang="en">Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C. Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials. Int J Cancer. 2008;123(6):1227-39. DOI: 10.1002/ijc.23754.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Simone CB, Simone NL, Simone V, Simone CB. Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, part 1. Altern. Ther. Health Med. 2007;13:22-28. PMID: 17283738.</mixed-citation><mixed-citation xml:lang="en">Simone CB, Simone NL, Simone V, Simone CB. Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, part 1. Altern. Ther. Health Med. 2007;13:22-28. PMID: 17283738.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Ma-On C, Sanpavat A, Whongsiri P, Suwannasin S, Hirankarn N, Tangkijvanich P. Oxidative stress indicated by elevated expression of Nrf2 and 8-OHdG promotes hepatocellular carcinoma progression. Med Oncol. 2017;34(4):57. DOI: 10.1007/s12032-017-09145.</mixed-citation><mixed-citation xml:lang="en">Ma-On C, Sanpavat A, Whongsiri P, Suwannasin S, Hirankarn N, Tangkijvanich P. Oxidative stress indicated by elevated expression of Nrf2 and 8-OHdG promotes hepatocellular carcinoma progression. Med Oncol. 2017;34(4):57. DOI: 10.1007/s12032-017-09145.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Choudhari SK, Chaudhary M, Gadbail AR, Sharma A, Tekade S. Oxidative and antioxidative mechanisms in oral cancer and precancer: a review. Oral Oncol. 2014;50(1):10-8. DOI: 10.1016/j. oraloncology.2013.09.011.</mixed-citation><mixed-citation xml:lang="en">Choudhari SK, Chaudhary M, Gadbail AR, Sharma A, Tekade S. Oxidative and antioxidative mechanisms in oral cancer and precancer: a review. Oral Oncol. 2014;50(1):10-8. DOI: 10.1016/j. oraloncology.2013.09.011.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Prasad S, Gupta SC, Tyagi AK. Reactive oxygen species (ROS) and cancer: role of antioxidative nutraceuticals. Cancer Lett. 2017;387:95-105. DOI: 10.1016/j.canlet.2016.03.042.</mixed-citation><mixed-citation xml:lang="en">Prasad S, Gupta SC, Tyagi AK. Reactive oxygen species (ROS) and cancer: role of antioxidative nutraceuticals. Cancer Lett. 2017;387:95-105. DOI: 10.1016/j.canlet.2016.03.042.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang B, Xiao S, Khan MA, Xue M. Defective antioxidant systems in cervical cancer. Tumour Biol. 2013;34(4):2003-9. DOI: 10.1007/s13277-013-0804-1.</mixed-citation><mixed-citation xml:lang="en">Jiang B, Xiao S, Khan MA, Xue M. Defective antioxidant systems in cervical cancer. Tumour Biol. 2013;34(4):2003-9. DOI: 10.1007/s13277-013-0804-1.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Le Gal K, Ibrahim MX, Wiel C, Sayin VI, Akula MK, Karlsson C, et al. Antioxidants can increase melanoma metastasis in mice. Sci Transl Med. 2015;7(308):308. DOI: 10.1126/scitranslmed.aad3740.</mixed-citation><mixed-citation xml:lang="en">Le Gal K, Ibrahim MX, Wiel C, Sayin VI, Akula MK, Karlsson C, et al. Antioxidants can increase melanoma metastasis in mice. Sci Transl Med. 2015;7(308):308. DOI: 10.1126/scitranslmed.aad3740.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Sayin VI, Ibrahim MX, Larsson E, Nilsson JA, Lindahl P, Bergo MO. Antioxidants accelerate lung cancer progression in mice. Sci Transl Med. 2014;6:221. DOI: 10.1126/scitranslmed.3007653.</mixed-citation><mixed-citation xml:lang="en">Sayin VI, Ibrahim MX, Larsson E, Nilsson JA, Lindahl P, Bergo MO. Antioxidants accelerate lung cancer progression in mice. Sci Transl Med. 2014;6:221. DOI: 10.1126/scitranslmed.3007653.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Park SJ, Myung SK, Lee Y, Lee YJ. Effects of vitamin and antioxidant supplements in prevention of bladder cancer: a meta-analysis of randomized controlled trials. J Korean Med Sci. 2017;32(4):628-35. DOI: 10.3346/jkms.2017.32.4.628.</mixed-citation><mixed-citation xml:lang="en">Park SJ, Myung SK, Lee Y, Lee YJ. Effects of vitamin and antioxidant supplements in prevention of bladder cancer: a meta-analysis of randomized controlled trials. J Korean Med Sci. 2017;32(4):628-35. DOI: 10.3346/jkms.2017.32.4.628.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Tong L, Chuang CC, Wu S, Zuo L. Reactive oxygen species in redox cancer therapy. Cancer Lett. 2015;367(1):18-25. DOI: 10.1016/j.canlet.2015.07.008.</mixed-citation><mixed-citation xml:lang="en">Tong L, Chuang CC, Wu S, Zuo L. Reactive oxygen species in redox cancer therapy. Cancer Lett. 2015;367(1):18-25. DOI: 10.1016/j.canlet.2015.07.008.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Watson J. Oxidants, antioxidants and the current incurability of metastatic cancers. Open Biol. 2013;3(1):120144. DOI:10.1098/rsob.120144.</mixed-citation><mixed-citation xml:lang="en">Watson J. Oxidants, antioxidants and the current incurability of metastatic cancers. Open Biol. 2013;3(1):120144. DOI:10.1098/rsob.120144.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013;12(12):931-47. DOI: 10.1038/nrd4002.</mixed-citation><mixed-citation xml:lang="en">Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013;12(12):931-47. DOI: 10.1038/nrd4002.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Smith DG, Magwere T, Burchill SA. Oxidative stress and therapeutic opportunities: focus on the Ewing’s sarcoma family of tumors. Expert Rev Anticancer Ther. 2011;11(2):229-49. DOI: 10.1586/era.10.224.</mixed-citation><mixed-citation xml:lang="en">Smith DG, Magwere T, Burchill SA. Oxidative stress and therapeutic opportunities: focus on the Ewing’s sarcoma family of tumors. Expert Rev Anticancer Ther. 2011;11(2):229-49. DOI: 10.1586/era.10.224.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Fang J, Seki T, Maeda H. Therapeutic strategies by modulating oxygen stress in cancer and inflammation. Adv Drug Deliv Rev. 2009;61(4):290302. DOI: 10.1016/j.addr.2009.02.005.</mixed-citation><mixed-citation xml:lang="en">Fang J, Seki T, Maeda H. Therapeutic strategies by modulating oxygen stress in cancer and inflammation. Adv Drug Deliv Rev. 2009;61(4):290302. DOI: 10.1016/j.addr.2009.02.005.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Saeidnia S, Abdollahi M. Antioxidants: friends or foe in prevention or treatment of cancer: the debate of the century. Toxicol Appl Pharmacol. 2013;271(1):4963. DOI: 10.1016/j.taap.2013.05.004.</mixed-citation><mixed-citation xml:lang="en">Saeidnia S, Abdollahi M. Antioxidants: friends or foe in prevention or treatment of cancer: the debate of the century. Toxicol Appl Pharmacol. 2013;271(1):4963. DOI: 10.1016/j.taap.2013.05.004.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Калинина ЕВ, Чернов НН, Саприн АН. Участие тио-, пероксии глутаредоксинов в клеточных редоксзависимых процессах. Успехи биологической химии. 2008;48:319-358. [Kalinina EV, Saprin AN, Chernov NN. Involvement of thio-, peroxi-, and glutaredoxins in cellular redox-dependent processes. Biochemistry (Moscow). 2008;73(13):1493-1510]. DOI: 10.1134/S0006297908130099.</mixed-citation><mixed-citation xml:lang="en">Калинина ЕВ, Чернов НН, Саприн АН. Участие тио-, пероксии глутаредоксинов в клеточных редоксзависимых процессах. Успехи биологической химии. 2008;48:319-358. [Kalinina EV, Saprin AN, Chernov NN. Involvement of thio-, peroxi-, and glutaredoxins in cellular redox-dependent processes. Biochemistry (Moscow). 2008;73(13):1493-1510]. DOI: 10.1134/S0006297908130099.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Nelson ME, Lahiri S, Chow JD, Byrne FL, Hargett SR, Breen DS, et al. Inhibition of hepatic lipogenesis enhances liver tumorigenesis by increasing antioxidant defence and promoting cell survival. Nat Commun. 2017;8:14689. DOI: 10.1038/ncomms14689.</mixed-citation><mixed-citation xml:lang="en">Nelson ME, Lahiri S, Chow JD, Byrne FL, Hargett SR, Breen DS, et al. Inhibition of hepatic lipogenesis enhances liver tumorigenesis by increasing antioxidant defence and promoting cell survival. Nat Commun. 2017;8:14689. DOI: 10.1038/ncomms14689.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Сидорова ТА, Вагида МС, Калия ОЛ, Герасимова ГК. Роль каталазы в защите опухолевых клеток от окислительного стресса, индуцированного бинарной каталитической системой «терафтал + аскорбиновая кислота». Клиническая онкогематология. 2014;7(3):282-289. [Sidorova TA, Vagida MS, Kaliya OL, Gerasimova GK. Role of catalase in protection of cancer cells from oxidative stress induced by binary catalytic system “teraphtal + ascorbic acid”. Clin Oncohematol. 2014;7(3):282-289 (in Russ.)].</mixed-citation><mixed-citation xml:lang="en">Сидорова ТА, Вагида МС, Калия ОЛ, Герасимова ГК. Роль каталазы в защите опухолевых клеток от окислительного стресса, индуцированного бинарной каталитической системой «терафтал + аскорбиновая кислота». Клиническая онкогематология. 2014;7(3):282-289. [Sidorova TA, Vagida MS, Kaliya OL, Gerasimova GK. Role of catalase in protection of cancer cells from oxidative stress induced by binary catalytic system “teraphtal + ascorbic acid”. Clin Oncohematol. 2014;7(3):282-289 (in Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Wang L, Luo X, Li C, Huang Y, Xu P, LloydDavies LH, et al. Triethylenetetramine synergizes with pharmacologic ascorbic acid in hydrogen peroxide mediated selective toxicity to breast cancer cell. Oxid Med Cell Longev. 2017;2017:3481710. DOI: 10.1155/2017/3481710.</mixed-citation><mixed-citation xml:lang="en">Wang L, Luo X, Li C, Huang Y, Xu P, LloydDavies LH, et al. Triethylenetetramine synergizes with pharmacologic ascorbic acid in hydrogen peroxide mediated selective toxicity to breast cancer cell. Oxid Med Cell Longev. 2017;2017:3481710. DOI: 10.1155/2017/3481710.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Hecht F, Cazarin JM, Lima CE, Faria CC, Leit o AA, Ferreira AC, et al. Redox homeostasis of breast cancer lineages contributes to differential cell death response to exogenous hydrogen peroxide. Life Sci. 2016;158:7-13. DOI: 10.1016/j.lfs.2016.06.016.</mixed-citation><mixed-citation xml:lang="en">Hecht F, Cazarin JM, Lima CE, Faria CC, Leit o AA, Ferreira AC, et al. Redox homeostasis of breast cancer lineages contributes to differential cell death response to exogenous hydrogen peroxide. Life Sci. 2016;158:7-13. DOI: 10.1016/j.lfs.2016.06.016.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Чернов АН, Яцков НН, Скакун ВВ. Исследование чувствительности клеток интракраниальных неоплазий к химиопрепаратам. Российский журнал детской гематологии и онкологии. 2015;2(4):51-57. [Chernov AN, Yatskov NN, Skakun VV. Research of the intracranial neoplasia cell sensitivity to chemotherapy drugs. Rus J Child Hematol Oncol. 2015;2(4):51-57 (in Russ.)].</mixed-citation><mixed-citation xml:lang="en">Чернов АН, Яцков НН, Скакун ВВ. Исследование чувствительности клеток интракраниальных неоплазий к химиопрепаратам. Российский журнал детской гематологии и онкологии. 2015;2(4):51-57. [Chernov AN, Yatskov NN, Skakun VV. Research of the intracranial neoplasia cell sensitivity to chemotherapy drugs. Rus J Child Hematol Oncol. 2015;2(4):51-57 (in Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Shah MH, Liu GS, Thompson EW, Dusting GJ, Peshavariya HM. Differential effects of superoxide dismutase and superoxide dismutase/catalase mimetics on human breast cancer cells. Breast Cancer Res Treat. 2015;150(3):523-34. DOI: 10.1007/s10549015-3329-z.</mixed-citation><mixed-citation xml:lang="en">Shah MH, Liu GS, Thompson EW, Dusting GJ, Peshavariya HM. Differential effects of superoxide dismutase and superoxide dismutase/catalase mimetics on human breast cancer cells. Breast Cancer Res Treat. 2015;150(3):523-34. DOI: 10.1007/s10549015-3329-z.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Герасименко МН, Зуков РА, Титова НМ, Дыхно ЮА, Модестов АА, Попов ДВ. Антиоксидантная система и маркеры окислительного стресса при раке почки. Сибирский онкологический журнал. 2012;5(53):39-43. [Gerasimenko MN, Zukov RA, Titova NM, Dvkhno YuA, Modestov AA, Popov DV. Antioxidant system and markers of oxidative stress in renal cell cancer. Siberian J Oncol. 2012;5(53):39-43 (in Russ.)].</mixed-citation><mixed-citation xml:lang="en">Герасименко МН, Зуков РА, Титова НМ, Дыхно ЮА, Модестов АА, Попов ДВ. Антиоксидантная система и маркеры окислительного стресса при раке почки. Сибирский онкологический журнал. 2012;5(53):39-43. [Gerasimenko MN, Zukov RA, Titova NM, Dvkhno YuA, Modestov AA, Popov DV. Antioxidant system and markers of oxidative stress in renal cell cancer. Siberian J Oncol. 2012;5(53):39-43 (in Russ.)].</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
